# Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures

> **NCT06242977** · PHASE3 · UNKNOWN · sponsor: **University of Manitoba** · enrollment: 72 (estimated)

## Conditions studied

- Scrotum Disease
- Hydrocele Male
- Spermatocele
- Scrotal Hematocele
- Local Anesthesia

## Interventions

- **DRUG:** Eutectic mixture of local anesthetics (EMLA; Astra Pharmaceutical Products Inc., Westborough, MA)
- **OTHER:** Control cream

## Key facts

- **NCT ID:** NCT06242977
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-25
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06242977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06242977, "Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06242977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*